Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

Sublines of the human small-cell lung carcinoma (SCLC) cell line GLC4 with acquired resistance to teniposide, amsacrine and mitoxantrone (GLC4/VM20x, GLC4/AM3x and GLC4/MIT60x, respectively) were derived to study the contribution of DNA topoisomerase II alpha and -beta (TopoII alpha and -beta) to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Withoff, S., de Vries, E. G., Keith, W. N., Nienhuis, E. F., van der Graaf, W. T., Uges, D. R., Mulder, N. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074800/
https://www.ncbi.nlm.nih.gov/pubmed/8980384
_version_ 1782138045750837248
author Withoff, S.
de Vries, E. G.
Keith, W. N.
Nienhuis, E. F.
van der Graaf, W. T.
Uges, D. R.
Mulder, N. H.
author_facet Withoff, S.
de Vries, E. G.
Keith, W. N.
Nienhuis, E. F.
van der Graaf, W. T.
Uges, D. R.
Mulder, N. H.
author_sort Withoff, S.
collection PubMed
description Sublines of the human small-cell lung carcinoma (SCLC) cell line GLC4 with acquired resistance to teniposide, amsacrine and mitoxantrone (GLC4/VM20x, GLC4/AM3x and GLC4/MIT60x, respectively) were derived to study the contribution of DNA topoisomerase II alpha and -beta (TopoII alpha and -beta) to resistance for TopoII-targeting drugs. The cell lines did not overexpress P-glycoprotein or the multidrug resistance-associated protein but were cross-resistant to other TopoII drugs. GLC4/VM20x showed a major decrease in TopoII alpha protein (54%; for all assays presented in this paper the GLC4 level was defined to be 100%) without reduction in TopoII beta protein; GLC4/AM3x showed only a major decrease in TopoII beta protein (to 18%) and not in TopoII alpha. In GLC4/MIT60x, the TopoII alpha and -beta protein levels were both decreased (TopoII alpha to 31%; TopoII beta protein was undetectable). The decrease in TopoII alpha protein in GLC4/VM20x and GLC4/MIT60x, was mediated by decreased TopoII alpha mRNA levels. Loss of TopoII alpha gene copies contributed to the mRNA decrease in these cell lines. Only in the GLC4/MIT60x cell line was an accumulation defect observed for the drug against which the cell line was made resistant. In conclusion, TopoII alpha and -beta levels were decreased differentially in the resistant cell lines, suggesting that resistance to these drugs may be mediated by a decrease in a specific isozyme. IMAGES:
format Text
id pubmed-2074800
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20748002009-09-10 Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4. Withoff, S. de Vries, E. G. Keith, W. N. Nienhuis, E. F. van der Graaf, W. T. Uges, D. R. Mulder, N. H. Br J Cancer Research Article Sublines of the human small-cell lung carcinoma (SCLC) cell line GLC4 with acquired resistance to teniposide, amsacrine and mitoxantrone (GLC4/VM20x, GLC4/AM3x and GLC4/MIT60x, respectively) were derived to study the contribution of DNA topoisomerase II alpha and -beta (TopoII alpha and -beta) to resistance for TopoII-targeting drugs. The cell lines did not overexpress P-glycoprotein or the multidrug resistance-associated protein but were cross-resistant to other TopoII drugs. GLC4/VM20x showed a major decrease in TopoII alpha protein (54%; for all assays presented in this paper the GLC4 level was defined to be 100%) without reduction in TopoII beta protein; GLC4/AM3x showed only a major decrease in TopoII beta protein (to 18%) and not in TopoII alpha. In GLC4/MIT60x, the TopoII alpha and -beta protein levels were both decreased (TopoII alpha to 31%; TopoII beta protein was undetectable). The decrease in TopoII alpha protein in GLC4/VM20x and GLC4/MIT60x, was mediated by decreased TopoII alpha mRNA levels. Loss of TopoII alpha gene copies contributed to the mRNA decrease in these cell lines. Only in the GLC4/MIT60x cell line was an accumulation defect observed for the drug against which the cell line was made resistant. In conclusion, TopoII alpha and -beta levels were decreased differentially in the resistant cell lines, suggesting that resistance to these drugs may be mediated by a decrease in a specific isozyme. IMAGES: Nature Publishing Group 1996-12 /pmc/articles/PMC2074800/ /pubmed/8980384 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Withoff, S.
de Vries, E. G.
Keith, W. N.
Nienhuis, E. F.
van der Graaf, W. T.
Uges, D. R.
Mulder, N. H.
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title_full Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title_fullStr Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title_full_unstemmed Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title_short Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
title_sort differential expression of dna topoisomerase ii alpha and -beta in p-gp and mrp-negative vm26, mamsa and mitoxantrone-resistant sublines of the human sclc cell line glc4.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074800/
https://www.ncbi.nlm.nih.gov/pubmed/8980384
work_keys_str_mv AT withoffs differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT devrieseg differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT keithwn differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT nienhuisef differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT vandergraafwt differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT ugesdr differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4
AT muldernh differentialexpressionofdnatopoisomeraseiialphaandbetainpgpandmrpnegativevm26mamsaandmitoxantroneresistantsublinesofthehumansclccelllineglc4

Ejemplares similares